Thomas Luebbers

1.3k total citations
18 papers, 868 citations indexed

About

Thomas Luebbers is a scholar working on Organic Chemistry, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Thomas Luebbers has authored 18 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 6 papers in Molecular Biology and 6 papers in Computational Theory and Mathematics. Recurrent topics in Thomas Luebbers's work include Computational Drug Discovery Methods (6 papers), Alzheimer's disease research and treatments (5 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Thomas Luebbers is often cited by papers focused on Computational Drug Discovery Methods (6 papers), Alzheimer's disease research and treatments (5 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Thomas Luebbers collaborates with scholars based in Switzerland, Germany and United Kingdom. Thomas Luebbers's co-authors include Karlheinz Baumann, Christian Haass, Harald Steiner, Hans Gmuender, Akio Fukumori, Dirk Kostrewa, Markus Boehringer, Werner Klaus, Holger Kuehne and Francis Mueller and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Thomas Luebbers

18 papers receiving 840 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Luebbers Switzerland 13 434 295 290 255 170 18 868
Roger E. Markwell United Kingdom 18 430 1.0× 316 1.1× 439 1.5× 164 0.6× 244 1.4× 42 1.1k
Xiaohong Yang China 10 224 0.5× 109 0.4× 139 0.5× 79 0.3× 160 0.9× 12 581
Isabel Dorronsoro Spain 12 452 1.0× 127 0.4× 412 1.4× 343 1.3× 442 2.6× 26 1.0k
Munikumar Reddy Doddareddy South Korea 21 551 1.3× 38 0.1× 292 1.0× 198 0.8× 99 0.6× 37 928
Moustafa T. Gabr United States 23 454 1.0× 110 0.4× 504 1.7× 216 0.8× 233 1.4× 95 1.3k
Pedro de Sena Murteira Pinheiro Brazil 11 289 0.7× 52 0.2× 310 1.1× 135 0.5× 153 0.9× 31 673
Ilya Okun United States 22 578 1.3× 161 0.5× 711 2.5× 122 0.5× 113 0.7× 66 1.3k
Jung‐Mi Hah South Korea 14 316 0.7× 150 0.5× 203 0.7× 129 0.5× 89 0.5× 38 625
Serena Scapecchi Italy 20 750 1.7× 58 0.2× 456 1.6× 78 0.3× 205 1.2× 82 1.3k
Annalina Lapucci Italy 16 307 0.7× 46 0.2× 446 1.5× 84 0.3× 135 0.8× 53 749

Countries citing papers authored by Thomas Luebbers

Since Specialization
Citations

This map shows the geographic impact of Thomas Luebbers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Luebbers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Luebbers more than expected).

Fields of papers citing papers by Thomas Luebbers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Luebbers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Luebbers. The network helps show where Thomas Luebbers may publish in the future.

Co-authorship network of co-authors of Thomas Luebbers

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Luebbers. A scholar is included among the top collaborators of Thomas Luebbers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Luebbers. Thomas Luebbers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ratni, Hasane, Karlheinz Baumann, Peter Bellotti, et al.. (2021). Phenyl bioisosteres in medicinal chemistry: discovery of novel γ-secretase modulators as a potential treatment for Alzheimer's disease. RSC Medicinal Chemistry. 12(5). 758–766. 15 indexed citations
2.
Brendel, Matthias, Anna Jaworska, Jochen Herms, et al.. (2015). Monitoring of chronic γ-secretase modulator treatment by serial amyloid-PET. Molecular Psychiatry. 20(10). 1141–1141. 2 indexed citations
3.
Brendel, Matthias, Anna Jaworska, Jochen Herms, et al.. (2015). Amyloid-PET predicts inhibition of de novo plaque formation upon chronic γ-secretase modulator treatment. Molecular Psychiatry. 20(10). 1179–1187. 37 indexed citations
4.
Fukumori, Akio, Richard Page, Thomas Luebbers, et al.. (2011). Attenuated Aβ42 Responses to Low Potency γ-Secretase Modulators Can Be Overcome for Many Pathogenic Presenilin Mutants by Second-generation Compounds. Journal of Biological Chemistry. 286(17). 15240–15251. 40 indexed citations
5.
Luebbers, Thomas, Akio Fukumori, Keiro Shirotani, et al.. (2011). Novel γ-Secretase Enzyme Modulators Directly Target Presenilin Protein. Journal of Biological Chemistry. 286(43). 37181–37186. 69 indexed citations
6.
Angehrn, Peter, Hans Gmuender, Paul Hebeisen, et al.. (2011). A New DNA Gyrase Inhibitor Subclass of the Cyclothialidine Family Based on a Bicyclic Dilactam−Lactone Scaffold. Synthesis and Antibacterial Properties. Journal of Medicinal Chemistry. 54(7). 2207–2224. 58 indexed citations
7.
Boehringer, Markus, Holger Fischer, Michael Hennig, et al.. (2009). Aryl- and heteroaryl-substituted aminobenzo[a]quinolizines as dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(3). 1106–1108. 38 indexed citations
8.
Winkler, Edith, Scott Hobson, Akio Fukumori, et al.. (2009). Purification, Pharmacological Modulation, and Biochemical Characterization of Interactors of Endogenous Human γ-Secretase. Biochemistry. 48(6). 1183–1197. 56 indexed citations
9.
Wang, Yi, et al.. (2008). Copper-catalyzed silylation of cyclopropenes using (trifluoromethyl)trimethylsilane. Chemical Communications. 1124–1124. 18 indexed citations
10.
Luebbers, Thomas, et al.. (2008). Synthesis and Application of Alkenylstannanes Derived from Base-Sensitive Cyclopropenes. Organic Letters. 10(18). 3993–3996. 12 indexed citations
11.
Joensuu, Pekka M., et al.. (2008). Diastereoselective Nickel-Catalyzed Reductive Aldol Cyclizations Using Diethylzinc as the Stoichiometric Reductant: Scope and Mechanistic Insight. Journal of the American Chemical Society. 130(23). 7328–7338. 25 indexed citations
12.
Page, Richard, Karlheinz Baumann, Masanori Tomioka, et al.. (2007). Generation of Aβ38 and Aβ42 Is Independently and Differentially Affected by Familial Alzheimer Disease-associated Presenilin Mutations and γ-Secretase Modulation. Journal of Biological Chemistry. 283(2). 677–683. 137 indexed citations
13.
14.
Lam, Hon Wai, et al.. (2006). Diastereoselective Cobalt-Catalyzed Reductive Aldol Cyclizations Using Diethylzinc as the Stoichiometric Reductant. Organic Letters. 8(17). 3729–3732. 26 indexed citations
15.
Angehrn, Peter, Stefan Buchmann, Christoph Funk, et al.. (2004). New Antibacterial Agents Derived from the DNA Gyrase Inhibitor Cyclothialidine. Journal of Medicinal Chemistry. 47(6). 1487–1513. 45 indexed citations
16.
Masciadri, Raffaello, Thomas Luebbers, Helmut Link, et al.. (2003). From the DNA Gyrase Inhibitor Cyclothialidine to a New Class of Antibacterial Agents. CHIMIA International Journal for Chemistry. 57(4). 184–184. 1 indexed citations
17.
Boehringer, Markus, Daniel Bur, Hans Gmuender, et al.. (2000). Novel Inhibitors of DNA Gyrase:  3D Structure Based Biased Needle Screening, Hit Validation by Biophysical Methods, and 3D Guided Optimization. A Promising Alternative to Random Screening. Journal of Medicinal Chemistry. 43(14). 2664–2674. 286 indexed citations
18.
Trost, Barry M., Louis Chupak, & Thomas Luebbers. (1998). ChemInform Abstract: Total Synthesis of (.+‐.)‐ and (+)‐Valienamine via a Strategy Derived from New Palladium‐Catalyzed Reactions.. ChemInform. 29(26). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026